Fund Holdings — Propel Bio Management, LLC

Total Portfolio Value:
$99.89M
Total Bought:
$23.14M
Total Sold:
$6.85M
Net Transaction:
+$16.29M
Notable People:
Leen Kawas, James Francis Harding
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Plains GP Holdings, L.P.LTD PARTNR INT A(PAGP)1,272,3601,272,3600$24.72M$23.21M23.23%-$1.51M
Achieve Life Sciences Inc6,153,0913,786,425-2,366,666$13.91M$11.93M11.94%-$1.98M
Akero Therapeutics Inc228,884228,8840$12.21M$10.87M10.88%-$1.35M
Milestone Pharmaceuticals Inc.(MIST)1,791,5575,124,890+3,333,333$3.48M$10.25M10.26%+$6.77M
Applied Therapeutics Inc11,285,42011,285,4200$3.51M$6.83M6.83%+$3.32M
Phathom Pharmaceuticals, Inc.(PHAT)922,927552,927-370,000$8.85M$6.51M6.51%-$2.34M
Abeona Therapeutics Inc.(ABEO)974,022974,0220$5.53M$5.14M5.15%-$389.6K
Delcath Systems, Inc.(DCTH)226,052438,509+212,457$3.07M$4.71M4.72%+$1.64M
Celldex Therapeutics, Inc.(CLDX)0155,000+155,000$0$4.01M4.01%+$4.01M
TScan Therapeutics, Inc.(TCRX)2,087,1391,932,304-154,835$3.03M$3.52M3.52%+$490.4K
COMPASS Pathways plcADS(CMPS)0510,000+510,000$0$2.92M2.93%+$2.92M
Nektar Therapeutics(NKTR)049,000+49,000$0$2.79M2.79%+$2.79M
Jasper Therapeutics, Inc.(JSPR)01,028,806+1,028,806$0$2.45M2.45%+$2.45M
Zevra Therapeutics, Inc.(ZVRA)231,874231,8740$2.04M$2.21M2.21%+$162.3K
Viridian Therapeutics, Inc.(VRDN)090,000+90,000$0$1.94M1.94%+$1.94M
LeonaBio, Inc.(LONA)0149,279+149,279$0$618.0K0.62%+$618.0K
WTS - Achieve Life SciCOMM3,699,9990-3,699,999$13.7K$0—-$13.7K
Capricor Therapeutics, Inc.COMM(CAPR)70,0000-70,000$695.1K$0—-$695.1K
Chinook TherapeuticsCOMM79,3570-79,357$2.5K$0—-$2.5K
Eiger BiopharmaceuticalsCOMM146,3810-146,381$423.0K$0—-$423.0K
Maat Pharma SacaCOMM94,1810-94,181$452.1K$0—-$452.1K
Athira Pharma IncCOMM1,492,7920-1,492,792$450.8K$0—-$450.8K
Page 1 of 1
Propel Bio Management, LLC — 13F Holdings — Q3 2025 | TickerTrail